{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:44:55Z","timestamp":1790034295709,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002280","name":"Plastic Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001279","name":"Orthopaedic Research and Education Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003021","name":"International Association of Fire Fighters Burn Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1006\/jsre.1999.5582","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T11:27:08Z","timestamp":1033990028000},"page":"136-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Site-Specific Immunosuppression using a New Formulation of Topical Cyclosporine A with Polyethylene Glycol-8 Glyceryl Caprylate\/Caprate"],"prefix":"10.1006","volume":"83","author":[{"given":"Hoang S.","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Malli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Chrzanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Puc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha S.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/jsre.1999.5582_RF1","first-page":"128","article-title":"Cyclosporine A, FK 506, and rapamycin: Binding to immunophilins and biological action","volume":"59","author":"Bierer","year":"1994","journal-title":"Chem. Immunol."},{"key":"10.1006\/jsre.1999.5582_RF2","series-title":"Recent Developments in Transplantation Medicine","year":"1994"},{"key":"10.1006\/jsre.1999.5582_RF3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01972366","article-title":"Cyclosporine: Immunology, toxicity and pharmacology in experimental animals","volume":"15","author":"Thomson","year":"1984","journal-title":"Agents Actions"},{"key":"10.1006\/jsre.1999.5582_RF4","first-page":"437","article-title":"Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeks","volume":"64","author":"Whiting","year":"1983","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1006\/jsre.1999.5582_RF5","series-title":"Local Immunosuppression of Organ Transplants","author":"Gruber","year":"1996"},{"key":"10.1006\/jsre.1999.5582_RF6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(86)90315-6","article-title":"Placebo-controlled trial of topical cyclosporin in severe alopecia areata","volume":"2","author":"De Prost","year":"1986","journal-title":"Lancet"},{"key":"10.1006\/jsre.1999.5582_RF7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archderm.1987.01660260033007","article-title":"Topical cyclosporine in alopecia areata","volume":"123","author":"Parodi","year":"1987","journal-title":"Arch. Dermatol."},{"key":"10.1006\/jsre.1999.5582_RF8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(86)90618-5","article-title":"Topical cyclosporin in alopecia areata and nickel contact dermatitis","volume":"2","author":"Thomson","year":"1986","journal-title":"Lancet"},{"key":"10.1006\/jsre.1999.5582_RF9","first-page":"582","article-title":"Topical cyclosporin A in nickel contact hypersensitivity: Results of a preliminary clinical and immunohistochemical investigation","volume":"66","author":"Aldridge","year":"1986","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/jsre.1999.5582_RF10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bjo.69.8.600","article-title":"Prolonged survival of allogeneic corneal grafts in rabbits treated with topically applied cyclosporin A: Systemic absorption and local immunosuppressive effect","volume":"69","author":"Foets","year":"1985","journal-title":"Br. J. Ophthalmol."},{"key":"10.1006\/jsre.1999.5582_RF11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/BF02154739","article-title":"The effect of topical cyclosporin A on rabbit cornea: A clinical and electron microscopic study","volume":"224","author":"Behrens-Baumann","year":"1986","journal-title":"Graefes Arch. Clin. Exp. Opthalmmol."},{"key":"10.1006\/jsre.1999.5582_RF12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bjo.71.3.239","article-title":"Topical steroid, cyclosporin A, and the outcome of rat corneal allografts","volume":"71","author":"Williams","year":"1987","journal-title":"Br. J. Ophthalmol."},{"key":"10.1006\/jsre.1999.5582_RF13","first-page":"660","article-title":"Transdermal application of cyclosporine prolongs skin allograft survival","volume":"20","author":"Black","year":"1988","journal-title":"Transplant Proc."},{"key":"10.1006\/jsre.1999.5582_RF14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/1523-1747.ep12876218","article-title":"Site-specific suppression of cell-mediated immunity by cyclosporine","volume":"94","author":"Black","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"10.1006\/jsre.1999.5582_RF15","first-page":"120","article-title":"Mechanism of site-specific immunosuppression","volume":"23","author":"Black","year":"1991","journal-title":"Transplant. Proc."},{"key":"10.1006\/jsre.1999.5582_RF16","first-page":"344","article-title":"Digital image analysis of major histocompatibility complex class I and class II expression during site-specific immune suppression with topical cyclosporine","volume":"27","author":"Tatem","year":"1995","journal-title":"Transplant Proc."},{"key":"10.1006\/jsre.1999.5582_RF17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00007890-199505270-00022","article-title":"Site-specific immune suppression with topical cyclosporine: Synergism with combined topical corticosteroid added during the maintenance phase","volume":"59","author":"Llull","year":"1995","journal-title":"Transplantation"},{"key":"10.1006\/jsre.1999.5582_RF18","series-title":"Local Immunosuppression of Organ Transplants","first-page":"141","article-title":"Site-specific immunosuppression with topical agents","author":"Black","year":"1996"},{"key":"10.1006\/jsre.1999.5582_RF19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00007890-198801000-00003","article-title":"Cyclosporine and skin allografts for the treatment of thermal injury: Extensive graft survival with low-level long-term administration and prolongation in a rat burn model","volume":"45","author":"Hewitt","year":"1988","journal-title":"Transplantation"},{"key":"10.1006\/jsre.1999.5582_RF20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00007890-198801000-00004","article-title":"Cyclosporine and skin allografts for the treatment of thermal injury: Development of an experimental massive third degree burn model demonstrating extensive graft survival","volume":"45","author":"Black","year":"1988","journal-title":"Transplantation"},{"key":"10.1006\/jsre.1999.5582_RF21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1398-9995.1971.tb01290.x","article-title":"The microcirculation in rat skin allograft during rejection and treatment with cortisone and Trasylol\u00ae","volume":"26","author":"Braendstrup","year":"1971","journal-title":"Acta Allergol."},{"key":"10.1006\/jsre.1999.5582_RF22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00007890-198707000-00018","article-title":"Long-term survival of skin allografts in rats treated with topical cyclosporine","volume":"44","author":"Lai","year":"1987","journal-title":"Transplantation"},{"key":"10.1006\/jsre.1999.5582_RF23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4065\/70.6.581","article-title":"Transcutaneous drug delivery: A practical review","volume":"70","author":"Berti","year":"1995","journal-title":"Mayo Clin. Proc."},{"key":"10.1006\/jsre.1999.5582_RF24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.me.39.020188.001253","article-title":"Transdermal delivery of drugs","volume":"39","author":"Brown","year":"1988","journal-title":"Annu. Rev. Med."},{"key":"10.1006\/jsre.1999.5582_RF25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/15569528609030991","article-title":"Penetration enhancers and the percutaneous absorption of drugs: An update","volume":"5","author":"Woodford","year":"1986","journal-title":"J. Toxicol. Cutan. Ocular Toxicol."},{"key":"10.1006\/jsre.1999.5582_RF26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archderm.1963.01590190026002","article-title":"Existence of reservoir in the stratum corneum","volume":"88","author":"Vickers","year":"1963","journal-title":"Arch. Dermatol."},{"key":"10.1006\/jsre.1999.5582_RF27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/1523-1747.ep12518298","article-title":"In vivo correlation between stratum corneum reservoir function and percutaneous absorption","volume":"81","author":"Rouger","year":"1983","journal-title":"J. Invest. Dermatol."},{"key":"10.1006\/jsre.1999.5582_RF28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/1523-1747.ep12260677","article-title":"In vivo relationship between horny layer reservoir effect and percutaneous absorption in human and rat","volume":"82","author":"Dupuis","year":"1984","journal-title":"J. Invest. Dermatol."},{"key":"10.1006\/jsre.1999.5582_RF29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/1523-1747.ep12461357","article-title":"Measurement of the stratum corneum drug reservoir to predict the therapeutic efficacy of topical iododoxyuridine for herpes simplex virus infection","volume":"89","author":"Shoth","year":"1987","journal-title":"J. Invest. Dermatol."},{"key":"10.1006\/jsre.1999.5582_RF30","unstructured":"Gattefoss\u00e9 Product List, 1995"},{"key":"10.1006\/jsre.1999.5582_RF31","unstructured":"Hewitt, C. W. Black, K. S. Methods for Inducing Site-Specific Immunosuppression and Composition of Site-Specific Immunosuppressants, 1996"},{"key":"10.1006\/jsre.1999.5582_RF32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.2042-7158.1991.tb03548.x","article-title":"Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: In-vitro, ex-vivo rat studies","volume":"43","author":"Panchagnula","year":"1991","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480499955828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480499955828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:35:51Z","timestamp":1758378951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480499955828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S0022480499955828"],"URL":"https:\/\/doi.org\/10.1006\/jsre.1999.5582","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[1999,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-Specific Immunosuppression using a New Formulation of Topical Cyclosporine A with Polyethylene Glycol-8 Glyceryl Caprylate\/Caprate","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/jsre.1999.5582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}